Published in Clin Infect Dis on June 01, 2008
Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol (2009) 10.42
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev (2010) 9.82
Community-associated meticillin-resistant Staphylococcus aureus. Lancet (2010) 9.07
Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest (2009) 3.24
Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States. Clin Infect Dis (2009) 2.31
High-density livestock operations, crop field application of manure, and risk of community-associated methicillin-resistant Staphylococcus aureus infection in Pennsylvania. JAMA Intern Med (2013) 2.27
Neutrophils in innate host defense against Staphylococcus aureus infections. Semin Immunopathol (2011) 2.17
Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev (2015) 1.94
Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall. Ann N Y Acad Sci (2012) 1.91
Progress toward a Staphylococcus aureus vaccine. Clin Infect Dis (2011) 1.72
Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections. Antimicrob Agents Chemother (2012) 1.68
Global fluoroquinolone resistance epidemiology and implictions for clinical use. Interdiscip Perspect Infect Dis (2012) 1.55
Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006. Antimicrob Agents Chemother (2009) 1.47
Staphylococcus aureus infections in US veterans, Maryland, USA, 1999-2008. Emerg Infect Dis (2011) 1.39
Diversity of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from inpatients of 30 hospitals in Orange County, California. PLoS One (2013) 1.37
Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus. Infect Genet Evol (2013) 1.34
The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Clin Microbiol Infect (2012) 1.34
Development of a vaccine against Staphylococcus aureus. Semin Immunopathol (2011) 1.32
Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study. BMC Infect Dis (2013) 1.32
Epidemics of community-associated methicillin-resistant Staphylococcus aureus in the United States: a meta-analysis. PLoS One (2013) 1.26
Trends and characteristics of culture-confirmed Staphylococcus aureus infections in a large U.S. integrated health care organization. J Clin Microbiol (2012) 1.20
Molecular pathogenesis of Staphylococcus aureus infection. Pediatr Res (2009) 1.13
Presence and molecular epidemiology of virulence factors in methicillin-resistant Staphylococcus aureus strains colonizing and infecting soldiers. J Clin Microbiol (2009) 1.13
Diversity of methicillin-resistant Staphylococcus aureus strains isolated from residents of 26 nursing homes in Orange County, California. J Clin Microbiol (2013) 1.12
A population-based study of the epidemiology and clinical features of methicillin-resistant Staphylococcus aureus infection in Pennsylvania, 2001-2010. Epidemiol Infect (2013) 1.11
To screen or not to screen for methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2010) 1.11
Concurrent epidemics of skin and soft tissue infection and bloodstream infection due to community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2012) 1.06
Internet queries and methicillin-resistant Staphylococcus aureus surveillance. Emerg Infect Dis (2011) 1.06
Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance? Semin Immunopathol (2011) 1.06
Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates. J Clin Microbiol (2010) 1.03
Lack of a major role of Staphylococcus aureus Panton-Valentine leukocidin in lower respiratory tract infection in nonhuman primates. Am J Pathol (2010) 1.01
Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia. J Infect Dis (2013) 1.01
Emergence of community-associated methicillin-resistant Staphylococcus aureus carriage in children in Cambodia. Am J Trop Med Hyg (2011) 1.00
Changing epidemiology of methicillin-resistant Staphylococcus aureus in Iceland from 2000 to 2008: a challenge to current guidelines. J Clin Microbiol (2010) 0.98
Differences in methicillin-resistant Staphylococcus aureus strains isolated from pediatric and adult patients from hospitals in a large county in California. J Clin Microbiol (2012) 0.97
Reduction of methicillin-resistant Staphylococcus aureus infection among veterans in Atlanta. Infect Control Hosp Epidemiol (2012) 0.96
Front-loaded linezolid regimens result in increased killing and suppression of the accessory gene regulator system of Staphylococcus aureus. Antimicrob Agents Chemother (2012) 0.93
Pediatricians' perspectives on the impact of MRSA in primary care: a qualitative study. BMC Pediatr (2009) 0.88
In vivo activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457. Antimicrob Agents Chemother (2009) 0.88
Discriminatory Indices of Typing Methods for Epidemiologic Analysis of Contemporary Staphylococcus aureus Strains. Medicine (Baltimore) (2015) 0.88
Molecular and phenotypic characteristics of methicillin-resistant and vancomycin-intermediate staphylococcus aureus isolates from patients with septic arthritis. J Clin Microbiol (2009) 0.86
Livestock-Associated MRSA: The Impact on Humans. Antibiotics (Basel) (2015) 0.86
Staphylococcal Panton-Valentine leukocidin induces pro-inflammatory cytokine production and nuclear factor-kappa B activation in neutrophils. PLoS One (2012) 0.86
Significantly larger numbers of methicillin-resistant Staphylococcus aureus bacteria are recovered from polymicrobial respiratory and wound sites by use of chromogenic primary media than by use of conventional culture. J Clin Microbiol (2010) 0.85
Community-associated methicillin-resistant Staphylococcus aureus case studies. Methods Mol Biol (2014) 0.84
Current status of Staphylococcus aureus infection in a central teaching hospital in Shanghai, China. BMC Microbiol (2013) 0.84
Antimicrobial susceptibilities of health care-associated and community-associated strains of methicillin-resistant Staphylococcus aureus from hospitalized patients in Canada, 1995 to 2008. Antimicrob Agents Chemother (2010) 0.83
Variability of SCCmec in the Zurich area. Eur J Clin Microbiol Infect Dis (2008) 0.83
Spontaneous staphylococcal cassette chromosome mec element excision in Staphylococcus aureus nasal carriers. J Clin Microbiol (2011) 0.83
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated from tertiary care hospitals. Pak J Med Sci (2014) 0.82
Skin and soft-tissue infections in suburban primary care: epidemiology of methicillin-resistant Staphylococcus aureus and observations on abscess management. BMC Res Notes (2011) 0.80
Antibiotic selection for purulent skin and soft-tissue infections in ambulatory care: a decision-analytic approach. Acad Pediatr (2009) 0.80
The population genetics of drug resistance evolution in natural populations of viral, bacterial and eukaryotic pathogens. Mol Ecol (2015) 0.79
Comparative Molecular Characteristics of Community-Associated and Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Isolates From Adult Patients in Northern Taiwan. Medicine (Baltimore) (2015) 0.78
Staphylococcus aureus - antimicrobial resistance and the immunocompromised child. Infect Drug Resist (2014) 0.78
Polymorphisms in HLA Class II Genes Are Associated With Susceptibility to Staphylococcus aureus Infection in a White Population. J Infect Dis (2015) 0.78
Molecular surveillance and population structure analysis of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in high-risk wards. J Clin Microbiol (2009) 0.77
Absence of the mecA Gene in Methicillin Resistant Staphylococcus aureus Isolated from Different Clinical Specimens in Shendi City, Sudan. Biomed Res Int (2015) 0.77
Socio-economic profile of patients with community-acquired skin and soft tissue infections in Delhi. Pathog Glob Health (2014) 0.75
Prolonged colonization with the methicillin-resistant Staphylococcus aureus strain USA300 among residents of extended care facilities. Infect Control Hosp Epidemiol (2010) 0.75
Pan-genomic perspective on the evolution of the Staphylococcus aureus USA300 epidemic. Microb Genom (2016) 0.75
Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated in serial cultures from the respiratory tract of children with cystic fibrosis. Pediatr Infect Dis J (2014) 0.75
The Lantibiotic NAI-107 Efficiently Rescues Drosophila melanogaster from Infection with Methicillin-Resistant Staphylococcus aureus USA300. Antimicrob Agents Chemother (2016) 0.75
Vancomycin Resistance in Staphylococcus aureus . Yale J Biol Med (2017) 0.75
Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis (2003) 13.83
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis (2011) 11.49
Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis (2005) 9.23
Community-associated meticillin-resistant Staphylococcus aureus. Lancet (2010) 9.07
Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci U S A (2004) 8.95
Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med (2005) 8.39
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med (2006) 8.20
How clonal is Staphylococcus aureus? J Bacteriol (2003) 7.97
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis (2011) 6.71
Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med (2012) 6.36
Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2003) 5.29
Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med (2008) 5.13
Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. N Engl J Med (2015) 4.80
High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med (2005) 4.77
Community-associated MRSA--resistance and virulence converge. N Engl J Med (2005) 4.15
The built environment and obesity: a systematic review of the epidemiologic evidence. Health Place (2009) 3.98
Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis (2007) 3.98
Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A (2009) 3.89
Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis (2006) 3.74
The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J Infect Dis (2008) 3.68
Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis (2002) 3.53
Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci U S A (2011) 3.53
National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med (2008) 3.46
Recommendations for medical management of adult lead exposure. Environ Health Perspect (2006) 3.38
Evolution of Staphylococcus aureus by large chromosomal replacements. J Bacteriol (2004) 3.33
Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest (2009) 3.24
Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci U S A (2010) 3.05
Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet (2005) 2.99
Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis (2008) 2.94
Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol (2005) 2.90
Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother (2007) 2.89
Seven novel variants of the staphylococcal chromosomal cassette mec in methicillin-resistant Staphylococcus aureus isolates from Ireland. Antimicrob Agents Chemother (2005) 2.87
Comparison of PCR-southern hybridization and quantitative real-time PCR for the detection of JC and BK viral nucleotide sequences in urine and cerebrospinal fluid. J Virol Methods (2004) 2.86
Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis (2004) 2.86
Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother (2003) 2.80
Determining the genetic structure of the natural population of Staphylococcus aureus: a comparison of multilocus sequence typing with pulsed-field gel electrophoresis, randomly amplified polymorphic DNA analysis, and phage typing. J Clin Microbiol (2002) 2.65
Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS One (2008) 2.62
MRSA epidemic linked to a quickly spreading colonization and virulence determinant. Nat Med (2012) 2.61
Global changes in Staphylococcus aureus gene expression in human blood. PLoS One (2011) 2.61
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. Int J Neuropsychopharmacol (2007) 2.60
A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic. Genome Res (2013) 2.59
Texaco and its consultants. Int J Occup Environ Health (2005) 2.55
CD8alphaalpha-mediated survival and differentiation of CD8 memory T cell precursors. Science (2004) 2.54
Analyses of clonality and the evolution of bacterial pathogens. Curr Opin Microbiol (2004) 2.47
Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis (2004) 2.46
A positive feedback mechanism governs the polarity and motion of motile cilia. Nature (2007) 2.44
Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus--and their relation to community-associated disease activity. J Infect Dis (2005) 2.34
High-density livestock operations, crop field application of manure, and risk of community-associated methicillin-resistant Staphylococcus aureus infection in Pennsylvania. JAMA Intern Med (2013) 2.27
Related clones containing SCCmec type IV predominate among clinically significant Staphylococcus epidermidis isolates. Antimicrob Agents Chemother (2003) 2.23
Associations of multiple metals with kidney outcomes in lead workers. Occup Environ Med (2012) 2.14
Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis. Antimicrob Agents Chemother (2003) 2.02
Host defense and pathogenesis in Staphylococcus aureus infections. Infect Dis Clin North Am (2009) 2.01
Role of SraP, a Serine-Rich Surface Protein of Staphylococcus aureus, in binding to human platelets. Infect Immun (2005) 1.99
Neighborhoods and obesity in older adults: the Baltimore Memory Study. Am J Prev Med (2006) 1.96
Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Environ Health Perspect (2006) 1.94
What is the early adulthood outcome of boys who bully or are bullied in childhood? The Finnish "From a Boy to a Man" study. Pediatrics (2007) 1.94
The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues. Environ Health Perspect (2006) 1.91
Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis (2003) 1.86
Evaluation of molecular typing methods in characterizing a European collection of epidemic methicillin-resistant Staphylococcus aureus strains: the HARMONY collection. J Clin Microbiol (2007) 1.85
Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages. Emerg Infect Dis (2004) 1.84
Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A (2012) 1.83
Lasagna plots: a saucy alternative to spaghetti plots. Epidemiology (2010) 1.83
Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2008) 1.82
Apolipoprotein e genotype, cortisol, and cognitive function in community-dwelling older adults. Am J Psychiatry (2008) 1.81
Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis (2009) 1.80
Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae. J Clin Microbiol (2003) 1.78
Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder. J Am Acad Child Adolesc Psychiatry (2007) 1.78
Improved multilocus sequence typing scheme for Staphylococcus epidermidis. J Clin Microbiol (2006) 1.77
Staphylococcus aureus Panton-Valentine leukocidin contributes to inflammation and muscle tissue injury. PLoS One (2009) 1.74
Clonal composition of Staphylococcus aureus isolates at a Brazilian university hospital: identification of international circulating lineages. J Clin Microbiol (2006) 1.69
Associations of low-level urine cadmium with kidney function in lead workers. Occup Environ Med (2010) 1.67
Low colonization prevalence of Staphylococcus aureus with reduced vancomycin susceptibility among patients undergoing hemodialysis in the San Francisco Bay area. Clin Infect Dis (2005) 1.65
Population structure of a hybrid clonal group of methicillin-resistant Staphylococcus aureus, ST239-MRSA-III. PLoS One (2010) 1.64
Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections. Antimicrob Agents Chemother (2012) 1.60
Confounding of the relation between homocysteine and peripheral arterial disease by lead, cadmium, and renal function. Am J Epidemiol (2006) 1.59
Jumping the barrier to beta-lactam resistance in Staphylococcus aureus. J Bacteriol (2003) 1.57
AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry (2004) 1.53
Associations of salivary cortisol with cognitive function in the Baltimore memory study. Arch Gen Psychiatry (2007) 1.52
Global TravEpiNet: a national consortium of clinics providing care to international travelers--analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011. Clin Infect Dis (2011) 1.51
A novel bactericidal fabric coating with potent in vitro activity against meticillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents (2008) 1.48
Bone lead levels and blood pressure endpoints: a meta-analysis. Epidemiology (2008) 1.48
Modeling age and retest processes in longitudinal studies of cognitive abilities. Psychol Aging (2004) 1.48
Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2004) 1.46
Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France. J Clin Microbiol (2006) 1.46
Multivariate modeling of age and retest in longitudinal studies of cognitive abilities. Psychol Aging (2005) 1.45
Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300. PLoS Pathog (2012) 1.44
Genetic diversity of arginine catabolic mobile element in Staphylococcus epidermidis. PLoS One (2009) 1.42
PBP 2a mutations producing very-high-level resistance to beta-lactams. Antimicrob Agents Chemother (2004) 1.39
Epidemiologic considerations in attention deficit hyperactivity disorder: a review and update. Child Adolesc Psychiatr Clin N Am (2008) 1.38
Cephalothin susceptibility testing as class representative for oral cephalosporins: is it time to move on? Diagn Microbiol Infect Dis (2013) 1.38